Invest now
Indoco Remedies share price
High risk
- ₹244.75(-0.14%)July 21, 2026 09:27:30 AM IST
- NSE
- BSE
- Vol : 56.50 K (NSE + BSE)Last 20 day avg : 195.37 K
Indoco Remedies is trading -0.14% lower at Rs 244.75 as compared to its last closing price. Indoco Remedies has been trading in the price range of 245.65 & 244.20. Indoco Remedies has given 5.48% in this year & -4.91% in the last 5 days. There are 4 analysts who have initiated coverage on Indoco Remedies. There are 0.00 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of -21.64 Crores in its last quarter.Listed peers of Indoco Remedies include Sun Pharmaceutical Industries (-0.76%), Divi's Laboratories (-0.57%), Torrent Pharmaceuticals (-0.67%).The Mutual Fund holding in Indoco Remedies was at 17.16% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Indoco Remedies was at 1.27% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 21 Jul 2026, 09:28 AM IST
- BetaHigh volatility1.58Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry1.16The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.08Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Indoco Remedies News
Indoco Remedies Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,941.35 | -0.76 | 4,65,783.92 | 38.74 | 5.6 | - | - |
| Divi's Laboratories | 7,280.00 | -0.57 | 1,93,261.12 | 74.01 | 11.59 | - | - |
| Torrent Pharmaceuticals | 4,969.50 | -0.67 | 1,68,242.93 | 76.16 | 20.12 | - | - |
| Cipla | 1,438.20 | -0.23 | 1,16,184.32 | 27.78 | 3.35 | - | - |
| Zydus Lifesciences | 1,142.95 | -0.32 | 1,13,914.26 | 21.38 | 4.28 | - | - |
Mutual Fund Ownership
View allIndoco Remedies Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-28 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-24 | Quarterly Results |
About the company Indoco Remedies
- IndustryBiotechnology & Drugs
- ISININE873D01024
- BSE Code532612
- NSE CodeINDOCO
Indoco Remedies Limited is an India-based fully integrated, research-oriented pharmaceutical company. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company caters to both Domestic and International markets. Its products include SENSODENT-K, HOMIDE, DEXOREN-S, LORCHEK-MR, SENSOFORM, KIDODENT, NINAF, KARVOL PLUS, CYCLOPAM, LIGNOX+ADRENLINE, NOXA, CITAL-UTI, RENOLEN, REXIDIN-M, CITAL, SENSODENT-KF, CARMICIDE, TOBAREN-DM, FEBREX PLUS, SCABEX, CLOBEN-G, MOFLOREN-BF, OTOREX, ZINCOREN, SENOLIN, LIGNOX, HEMSYL, FEDRIS, REXIDIN, VEPAN, OXIPOD, TURBOCORT, MACUCHEK, and DENTOGEL. The Company has around 11 manufacturing facilities, seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs), supported by a research and development center and a clinical research organization facility.
Indoco Remedies Share Price FAQs
Indoco Remedies is trading at 244.75 as on Tue Jul 21 2026 03:57:30. This is -0.14% lower as compared to its previous closing price of 246.65.
The market capitalization of Indoco Remedies is 2266.90 Cr as on Tue Jul 21 2026 03:57:30.
The average broker rating on Indoco Remedies is Sell. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 3 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Indoco Remedies is 348.10 whereas the 52 wk low is 163.70
Indoco Remedies can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: -
- Dividend Yield: 0.08%
- D/E ratio: 1.16
Indoco Remedies reported a net profit of -95.15 Cr in 2026.
The Mutual Fund Shareholding was 17.16% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Indoco Remedies QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.